NR1H4 and hyperlipidemia: The application of Parabacteroides distasonis can significantly alter the bile acid profile, increase lithocholic acid and ursodeoxycholic acid, and increase the level of succinate in the intestine, which in turn reduce hyperlipidemia via the activation of the farnesoid X receptor pathway to repair intestinal barrier integrity (38).